GHK-CU comes along and lifts the rug
If no units are sold, a loss is incurred equal to total fixed costs of $50,000
The rats treated with BPC 157 exhibited resolved tail spasticity by day 15 post-injury while the rats in the control group did not exhibit sustained spasticity until day 360 [3]
WHAT TO EXPECT Different peptides have different timelines
Peptide Amount % of Blend GHK-Cu (copper tripeptide) 50 mg 62.5% BPC-157 10 mg 12.5% TB-500 (thymosin beta-4 fragment) 10 mg 12.5% KPV (lysine-proline-valine) 10 mg 12.5% Total 80 mg 100% In a research context, each component maps to a distinct literature: GHK-Cu is the most-studied copper tripeptide, investigated for extracellular matrix remodeling and collagen-related signaling (Pickart & Margolina, 2018)
Pandi-Perumal SR, Monti JM, Burman D, Karthikeyan R, BaHammam AS, Spence DW, et al